Market players are focusing on product innovation as well as partnership, acquisitions and collaborations to achieve better exposure of their products.
ROCKVILLE, MD / ACCESSWIRE / December 7, 2020 / The global biobanking market is likely to exhibit a robust CAGR of 7% during the assessment period (2020-2027). Growing need for disease-specific biosamples, particularly tumor cells to fast-track precision medicine research, is projected to fuel the market in the foreseeable future. Rising focus on expansion of novel therapies, for instance personalized medicine, is likely to fuel the market.
"Although the biospecimen application for the expansion of therapeutics is rising, there would be a noteworthy spurt in the implementation rate of bio-samples for clinical diagnosis to apprehend cell structure" says a Fact.MR analyst.
Request a report sample to gain comprehensive market insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=4438
Key Takeaways
- Asia Pacific will be recording the maximum CAGR of about 8% over the projected period.
- Software & services will be deployed at the utmost CAGR of about 7.5% in the market.
- Blood products will remain vital biospecimen in the global market throughout the assessment period.
- Therapeutics application is likely to come out as a dominant segment in the biobanking market
- Automated storage systems will reflect a CAGR of 7% during 2020-2027.
Drivers
- Rise in genomic research activities to study diseases is catalysing market growth.
- Progressions in biobanking and rising trend of preserving cord blood stem cells of newborns will be bolstering the growth of the biobanking market.
- Private and government funding to sustain regenerative medicine research will fuel market expansion.
- Rising need for cost-efficient drug development and discovery is boosting the global market.
- Rising trend of personalised medicines to diminish mortality rates triggered by chronic diseases is driving demand for biobanks.
Constraints
- Higher operational cost concerns foretell limited acceptance of biobank products
- Rising focus on the research & development of cell therapies to restrain the biobanking market.
Anticipated Market Impact by COVID-19 Outbreak
The COVID-19 outbreak has brought prominence of biobanks to the forefront across the globe. Therefore, quick establishment of a COVID-19 biobank are being foreseen all over the world to prospectively gather research biospecimens as well as corresponding patient provided and clinical data from COVID-19 patients with long-established infection with the COVID-19 virus to allow high-quality research.
Explore the global biobanking market with 80 figures, 52 data tables, along with the table of contents of the report. You can also find detailed segmentation on https://www.factmr.com/report/4438/biobanking-market
Competition Landscape
Major players identified in the biobanking market are Tecan Trading AG, Thermo Fisher Scientific, Inc., PHC Holdings Corporation (Panasonic Healthcare), Hamilton Company, Merck KGaA, Brooks Automation, Inc., Greiner AG, Chart Industries, Inc., QIAGEN N.V. and VWR International, LLC. Players are engaged in expansion of cryopreservation and temperature control systems to upkeep biobanking operations. Moreover, players are focusing on strengthening their market presence by extending their offerings to biobanking services.
More on the Report
The Fact.MR's market research report provides in-depth insights into the Biobanking market. The market is scrutinized on the basis of product (equipment, consumables, software & services), biospecimen (blood products, human tissues, cell lines, nucleic acids, and others), application (therapeutics, clinical diagnostics, drug discovery & development, and others), and storage (manual and automated), across seven major regions (North America, Europe, East Asia, South Asia, Oceania, Latin America, and Middle East & Africa (MEA).
Explore Wide-ranging Coverage of Fact.MR's Healthcare Landscape
Blood Bank Analyzers Market: Find insights on blood bank analyzers market with analysis of segments, statistics, influencers, market players, and business strategies adopted over the forecast period of 2019 to 2029.
Blood Transfusion Diagnostics Market: Fact.MR's report on the blood transfusion diagnostics market offers insights on the market during 2020 to 2025, including restraints, revenue sources, market leaders, and market strategies.
Biobanking Equipment Market: Read an analysis of the biobanking equipment market with insights on growth factors, opportunities, restraints, regional market forecast, regulatory policies, and strengths of market leaders.
About Fact.MR
Fact.MR is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Fact.MR is headquartered in Dublin, and has offices in Dubai. Fact.MR's latest market research reports industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.
Contact:
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: [email protected]
Web: https://www.factmr.com/
PR- https://www.factmr.com/media-release/1219/global-biobanking-market
SOURCE: FactMR